Tamareille, Sophie <br/><br/>
Myocardial reperfusion injury management: erythropoietin compared with postconditioning.  [electronic resource] 

 -  American journal of physiology. Heart and circulatory physiology  Dec 2009 
 - H2035-43 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-1539 
<br/><br/><label>Standard No.: </label>10.1152/ajpheart.00472.2009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cardiotonic Agents--therapeutic use<br/>Coronary Circulation--drug effects<br/>Darbepoetin alfa<br/>Disease Models, Animal<br/>Erythropoietin--analogs & derivatives<br/>Female<br/>Glycogen Synthase Kinase 3--metabolism<br/>Glycogen Synthase Kinase 3 beta<br/>Heart Rate--drug effects<br/>Mitogen-Activated Protein Kinase 1--antagonists & inhibitors<br/>Mitogen-Activated Protein Kinase 3--antagonists & inhibitors<br/>Myocardial Infarction--enzymology<br/>Myocardial Reperfusion Injury--enzymology<br/>Myocardium--enzymology<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Phosphorylation<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Rats<br/>Rats, Wistar<br/>Time Factors<br/>Ventricular Function, Left--drug effects<br/>Ventricular Pressure--drug effects